|Articles|June 14, 2013
Strategic Outsourcing Debate
Lisa Henderson discusses the debate around aligning of sponsor and CRO in a more integrated way to run clinical trials from a project or portfolio standpoint and gain efficiencies and ultimately save money.
Advertisement
Lisa Henderson on the debate surrounding strategic outsourcing, which is the aligning of sponsor and CRO in a more integrated way to run clinical trials from a project or portfolio standpoint and gain efficiencies and ultimately save money.
Additional links:
- April 2013 article,
Challenging the Value of Strategic Partnerships in Clinical Trial Outsourcing .
- PAREXEL's
Strategic Partnerships 2013 .
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
3
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
4
What Clinical Trials Can Learn from the Gig Economy About Payments
5